midostaurin,gemtuzumab ozogamicin
novartis,UCB Pharmaceuticals,pfizer
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'midostaurin']
 #ash22 ncri aml19 trial no benefit of flag-ida-go in cbf! though benefit was seen flt3 aml, should not be given instead of flt3i combination. #leusm #ash22 
Assistant Professor @MayoCancerCare @MayoClinic Alumni @MDAndersonNews. Interest in Acute Leukemia and Chronic myeloid disorders. Views are my own